Cargando…

RUNX2 as a promising therapeutic target for malignant tumors

The transcription factor runt-related protein 2 (RUNX2) has an important impact on the transformation of bone marrow mesenchymal stem cells to osteoblasts. Further studies have shown that RUNX2 plays a key role in the invasion and metastasis of cancers. RUNX2 is a “key” molecule in the regulatory ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Weizhu, Yang, Haiying, Chai, Jie, Xing, Ligang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981165/ https://www.ncbi.nlm.nih.gov/pubmed/33758548 http://dx.doi.org/10.2147/CMAR.S302173

Ejemplares similares

RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
por: Mikami, Masamitsu, et al.
Publicado: (2022)

RUNX2-modifying enzymes: therapeutic targets for bone diseases
por: Kim, Woo-Jin, et al.
Publicado: (2020)

RUNX1: an emerging therapeutic target for cardiovascular disease
por: Riddell, Alexandra, et al.
Publicado: (2020)

RUNX Family as a Promising Biomarker and a Therapeutic Target in Bone Cancers: A Review on Its Molecular Mechanism(s) behind Tumorigenesis
por: Vimalraj, Selvaraj, et al.
Publicado: (2023)

Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
por: Song, Xiaotian, et al.
Publicado: (2021)

The RUNX1/RUNX1T1 network: translating insights into therapeutic options
por: Swart, Laura E., et al.
Publicado: (2021)

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors
por: Gu, Yu, et al.
Publicado: (2014)

MiR-29a: a potential therapeutic target and promising biomarker in tumors
por: Wang, Jin-yan, et al.
Publicado: (2018)

Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features
por: Zhao, Weizhu, et al.
Publicado: (2023)

Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion
por: Yun, Jae Won, et al.
Publicado: (2019)

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
por: Kodama, Yuta, et al.
Publicado: (2021)

RUNX family: Oncogenes or tumor suppressors
por: Otálora-Otálora, Beatriz Andrea, et al.
Publicado: (2019)

RUNX2 and Cancer
por: Lin, Tsung-Chieh
Publicado: (2023)

Thrombospondin-1 Is a Putative Target Gene of Runx2 and Runx3
por: Shi, Xiuming, et al.
Publicado: (2013)

RUNX1: A MicroRNA Hub in Normal and Malignant Hematopoiesis
por: Rossetti, Stefano, et al.
Publicado: (2013)

EZH2 in Bladder Cancer, a Promising Therapeutic Target
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015)

Coronavirus 2′-O-methyltransferase: A promising therapeutic target
por: Schindewolf, Craig, et al.
Publicado: (2023)

Beyond Pathogenic RUNX1 Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies
por: Förster, Alisa, et al.
Publicado: (2022)

P-TEFb as A Promising Therapeutic Target
por: Fujinaga, Koh
Publicado: (2020)

Oligoadenylate synthetases-like is a prognostic biomarker and therapeutic target in pancreatic ductal adenocarcinoma
por: Chen, Shihong, et al.
Publicado: (2022)

Sirtuins: Promising Therapeutic Targets to Treat Ischemic Stroke
por: Liu, Yue, et al.
Publicado: (2023)

Targeted Delivery of siRNA Therapeutics to Malignant Tumors
por: Leng, Qixin, et al.
Publicado: (2017)

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
por: Xiao, Cuicui, et al.
Publicado: (2020)

Extracellular Vesicles in Bone Metastasis: Key Players in the Tumor Microenvironment and Promising Therapeutic Targets
por: Tamura, Takaaki, et al.
Publicado: (2020)

Targeting KRAS in Cancer: Promising Therapeutic Strategies
por: Mustachio, Lisa Maria, et al.
Publicado: (2021)

Update on FXR Biology: Promising Therapeutic Target?
por: Han, Chang Yeob
Publicado: (2018)

c-Met: A Promising Therapeutic Target in Bladder Cancer
por: Feng, Yanfei, et al.
Publicado: (2022)

Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with RUNX1-RUNX1T1 or CBFB-MYH11 Fusions
por: Qin, Wei, et al.
Publicado: (2022)

Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma
por: Dixit, Shivani, et al.
Publicado: (2022)

IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies
por: Wiese, Wojciech, et al.
Publicado: (2022)

Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors
por: Omran, Ziad, et al.
Publicado: (2021)

BCL-2 as therapeutic target for hematological malignancies
por: Perini, Guilherme Fleury, et al.
Publicado: (2018)

Pyroptosis: A promising therapeutic target for noninfectious diseases
por: Li, Tong, et al.
Publicado: (2021)

Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
por: Togo, Shinsaku, et al.
Publicado: (2013)

Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis
por: Abdelaziz Mohamed, Iman, et al.
Publicado: (2019)

miRNA: A Promising Therapeutic Target in Cancer
por: Menon, Amrutha, et al.
Publicado: (2022)

Therapeutic potential of tumor treating fields for malignant brain tumors
por: Zhou, Youyou, et al.
Publicado: (2023)

Targeting tumor innervation: premises, promises, and challenges
por: Li, Xinyu, et al.
Publicado: (2022)

Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
por: Li, Ruyi, et al.
Publicado: (2021)

Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ibk3h1frnkv10i7pd6ok8mj9go